EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor–ligand signaling complex

Jialiu Zeng, Gavin Wen Zhao Loi, Eka Norfaishanty Saipuljumri, Marco Antonio Romero Durán, Octavio Silva-García, Jose Manuel Perez-Aguilar iD, Víctor M Baizabal-Aguirre iD, Chih Hung Lo

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2308132121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Jialiu Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Type I, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NTU | Lee Kong Chian School of Medicine, Nanyang Technological University (LKCMedicine), Nanyang Technological University (NTU), Momental Foundation (Mistletoe Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor necrosis factor (TNF) receptor 1 (TNFR1) plays a pivotal role in mediating TNF induced downstream signaling and regulating inflammatory response. Recent studies have suggested that TNFR1 activation involves conformational rearrangements of preligand assembled receptor dimers and targeting receptor conformational dynamics is a viable strategy to modulate TNFR1 signaling. Here, we used a combination of biophysical, biochemical, and cellular assays, as well as molecular dynamics simulation to show that an anti-inflammatory peptide (FKCRRWQWRMKK), which we termed FKC, inhibits TNFR1 activation allosterically by altering the conformational states of the receptor dimer without blocking receptor–ligand interaction or disrupting receptor dimerization. We also demonstrated the efficacy of FKC by showing that the peptide inhibits TNFR1 signaling in HEK293 cells and attenuates inflammation in mice with intraperitoneal TNF injection. Mechanistically, we found that FKC binds to TNFR1 cysteine-rich domains (CRD2/3) and perturbs the conformational dynamics required for receptor activation. Importantly, FKC increases the frequency in the opening of both CRD2/3 and CRD4 in the receptor dimer, as well as induces a conformational opening in the cytosolic regions of the receptor. This results in an inhibitory conformational state that impedes the recruitment of downstream signaling molecules. Together, these data provide evidence on the feasibility of targeting TNFR1 conformationally active region and open new avenues for receptor-specific inhibition of TNFR1 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Tumor Necrosis Factor, Type ISignal TransductionMiceHumansAnimalsLigandsHEK293 CellsTumor Necrosis Factor-alphaPeptides

Stichwörter der Autor:innen

TNFR1 signalinganti-inflammatoryconformational dynamicsnoncompetitive inhibitionreceptor-specific inhibition

Substanzen

Receptors, Tumor Necrosis Factor, Type ILigandsTumor Necrosis Factor-alphaPeptides

Autor:innen und Institutionen

  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
  • School of Applied Science, Republic Polytechnic, Singapore 738964, Singapore.
  • Centro Multidisciplinario de Estudios en Biotecnología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58893, México.
  • School of Chemical Sciences, Meritorious Autonomous University of Puebla, University City, Puebla 72570, México.

ORCID-Profile: Jose Manuel Perez-Aguilar, Víctor M Baizabal-Aguirre

Förderung

  • NTU | Lee Kong Chian School of Medicine, Nanyang Technological University (LKCMedicine)
  • Nanyang Technological University (NTU)
  • Momental Foundation (Mistletoe Foundation)
  • Universidad Michoacana de San Nicolás de Hidalgo (UMSNH)

Zitieren

APA

Zeng, J., Loi, G. W. Z., Saipuljumri, E. N., Romero Durán, M. A., Silva-García, O., Perez-Aguilar, J. M., Baizabal-Aguirre, V. M., & Lo, C. H. (2024). Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor–ligand signaling complex. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2308132121

Vancouver

Zeng J, Loi GWZ, Saipuljumri EN, Romero Durán MA, Silva-García O, Perez-Aguilar JM, et al. Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor–ligand signaling complex. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2308132121

BibTeX
@article{Zeng2024,
  author = {Zeng, Jialiu and Loi, Gavin Wen Zhao and Saipuljumri, Eka Norfaishanty and Romero Durán, Marco Antonio and Silva-García, Octavio and Perez-Aguilar, Jose Manuel and Baizabal-Aguirre, Víctor M and Lo, Chih Hung},
  title = {Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor–ligand signaling complex},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2308132121}
}
Kostenlos starten →